News Coverage 10.17.19 By: Frank Vinluan Share on Twitter Share on Facebook Share on LinkedIn ArsenalBio Launches With $85M for “Programmable” T Cell Therapies Related Announcement, Our Impact PICI Network Researchers at #ASCO23 Announcement, Partner Highlight Guardant Health, PICI Launch Research Collaboration Announcement, Our Impact PICI Network Researchers at #AACR23